VDP: Vidipha Central Pharmaceutical Joint Stock Company - Summary | Jitta

Vidipha Central Pharmaceutical Joint Stock Company

VNM:VDP

Price
₫50,300.00
Loss Chance
57.9%
1.85JITTA SCORE
140.34%Over Jitta Line
Jitta Ranking
514 / 559
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (18)
Recent Business Performance (36)
Financial Strength (33)
Return to Shareholders (0)
Competitive Advantage (18)
Jitta Signs
Debt LevelLow Long Term Debt
Recent Business PerformanceEarning decline 11.16% in the last year
Key Stats
Jitta Score
Jitta Line
1.85
140.34%
4.40
156.47%
4.13
141.61%
Pharmaceuticals
5.90
77.58%
4.60
120.38%
3.71
> 1,000%
COMPANY DESCRIPTION
Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products in Vietnam. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamins, minerals, antiseptics, and others. The company also engages in the hotel and real estate businesses; and provision of drug storage and testing, and technology transfer consulting services. In addition, it produces, trades, imports, and exports medical herbs, raw materials, chemicals, cosmetics, food, medical equipment, and supplies. The company distributes its products through pharmaceutical companies, hospitals, and pharmacies. It also exports its products. Vidipha Central Pharmaceutical Joint Stock Company was founded in 2003 and is headquartered in Ho Chi Minh City, Vietnam.